The Clorox Company (CLX)
NYSE: CLX · Real-Time Price · USD
109.46
+1.26 (1.16%)
At close: Nov 13, 2026, 4:00 PM EST
109.55
+0.09 (0.08%)
After-hours: Nov 13, 2026, 7:55 PM EST
The Clorox Company Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, The Clorox Company stock has a consensus rating of "Hold" and an average price target of $97. The average 1-year stock price forecast is 11.38% lower than the current stock price, while the lowest is $74 (-32.40%) and the highest is $142 (+29.73%).
Price Target: $97 (-11.38%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for The Clorox Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 13 | 14 | 14 | 14 | 14 | 14 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 2 | 2 | 2 | 2 | 2 | 1 |
| Total | 19 | 19 | 19 | 19 | 19 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $87 → $94 | Hold | Maintains | $87 → $94 | -14.12% | Nov 4, 2026 |
| Goldman Sachs | Goldman Sachs | Sell Maintains $74 | Sell | Maintains | $74 | -32.40% | Nov 4, 2026 |
| UBS | UBS | Hold Maintains $91 → $96 | Hold | Maintains | $91 → $96 | -12.30% | Nov 3, 2026 |
| J.P. Morgan | J.P. Morgan | Sell Reiterates $83 → $86 | Sell | Reiterates | $83 → $86 | -21.43% | Nov 3, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Maintains $100 → $96 | Hold | Maintains | $100 → $96 | -12.30% | Nov 3, 2026 |
Financial Forecast
Revenue This Year
7.64B
from 6.72B
Increased by 13.66%
Revenue Next Year
7.81B
from 7.64B
Increased by 2.23%
EPS This Year
5.72
from 5.53
Increased by 3.49%
EPS Next Year
6.17
from 5.72
Increased by 7.79%
EPS based on non-GAAP adjusted numbers.